Mr Nicholas Duggan

Director

United Kingdom

Research Interests

Organoids, Personalised medicine, Stratified medicone, Precision medicine

Cellesce is developing technology to use cells from cancer biopsy to generate and grow organoids in 3D that can be used to screen available drugs (and combinations) and identify the optimum treatment. This development work builds on advances in microfluidics and 'organ-on-a-chip' technology. Cellesce is eager to partner with clinical researchers and technology specialists as we develop, pilot and prove our approach.